GLP-1 telehealth in New York: everything's on the menu
New York residents get the full national menu — every branded program, both manufacturer-direct channels, and all major compounded programs serve the state. The only quirk our research surfaced: New York's laboratory rules complicate the mail-in at-home lab kits some programs use (Noom's branded-med path notes lab limitations for NY, NJ, and RI residents), which can mean using a local Quest/Labcorp draw instead of a home kit. Minor, but worth knowing before an intake asks for labs.
| Option | Available in NY? | Ongoing cost | Notes |
|---|---|---|---|
| Manufacturer direct (Foundayo, Wegovy pill, Zepbound vials) | Yes | $149–449/mo | FDA-approved; any licensed prescriber |
| Mochi Health (compounded) | Yes | ~$178/mo | Video visit; cancel anytime; compounded meds not FDA-approved |
| SkinnyRx (compounded) | Yes | $199+/mo | Async; multiple formulations |
| Found (compounded) | Yes | $169+/mo | 12-mo plan pricing; $99 early-exit fee |
| MEDVi (compounded) | Yes | $299/mo | FDA warning letter Feb 2026 |
| Ro / Hims / LifeMD (branded) | Yes | ~$298–598/mo | Membership + branded med; possible local lab draw instead of home kit |
What we'd do in New York
Full availability means the decision is the standard framework: insurance first (New York's large-employer plans cover GLP-1s more often than most — a $25/month copay path is genuinely common here), then the FDA-approved pills at $149–199/month, then the compounded discount question with eyes open. Full numbers in the cost guide.